English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Novartis
Patient Daily
| May 7, 2023
Novartis Cosentyx® gains positive CHMP opinion for hidradenitis suppurativa
Patient Daily
| May 7, 2023
Novartis to present new data across oncology portfolio including Kisqali Phase III NATALEE trial in early breast cancer at ASCO
Patient Daily
| May 7, 2023
Novartis Phase III APPOINT-PNH trial shows investigational oral monotherapy iptacopan improves hemoglobin to near-normal levels, leading to transfusion independence in all treatment-naïve PNH patients
Patient Daily
| May 7, 2023
Novartis delivers strong sales growth, robust margin expansion and major innovation milestones. Raises FY guidance
Carol Ostrow
| Feb 7, 2019
Novartis says Cosentyx better at clearing skin in psoriasis patients than Stelara
Press release submission
| Dec 5, 2018
NOVARTIS: Announces longer-term analyses from pivotal Kymriah® trials that showed durable responses are maintained in patients with advanced blood cancers
Press releases submission
| May 15, 2018
NOVARTIS: Alcon Cares Project 100 Commits to Reducing Cataract Blindness Globally
Carrie Bradon
| Dec 1, 2017
Novartis announces positive results of MONALEESA-7 trial
Trending
+
Pharmaceuticals
Patient Daily
| Jun 30, 2025
PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
American Lung Association launches campaign for World Bronchiectasis Day
+
Pharmaceuticals
Patient Daily
| Jul 1, 2025
Coalition warns against potential impact of H.R. 1 on patient healthcare access
1
2
3
»
Last »
